UK markets closed

Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.9500-0.0500 (-1.65%)
As of 12:43PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
55.18
55.18
140.108
164.994
28.881
Operating expenses
Research development
11,521
11,521
8,377
7,164
2,259
Selling general and administrative
10,788
10,788
9,540
6,827
1,249
Total operating expenses
22,308
22,308
17,917
13,991
3,508
Operating income or loss
-22,253
-22,253
-17,777
-13,826
-3,479
Total other income/expenses net
-429.346
-429.346
-96.074
-72.92
-96.484
Income before tax
-22,188
-22,188
-17,498
-13,887
-3,572
Income tax expense
79.275
79.275
92.976
4.008
5.386
Income from continuing operations
-22,268
-22,268
-17,591
-13,891
-3,578
Net income
-22,268
-22,268
-17,591
-13,891
-3,578
Net income available to common shareholders
-22,268
-22,268
-17,591
-13,891
-3,578
Basic EPS
-1.81
-
-1.48
-1.37
-1.33
Diluted EPS
-1.81
-
-1.48
-1.37
-1.33
Basic average shares
12,227
-
11,883
10,165
2,681
Diluted average shares
12,227
-
11,883
10,165
2,681